squibb ltsqb interest buy cetus robert fild presid chief execut cetus corp ltctuso told reuter squibb corp interest buy cetus earlier compani squibb buy cetus pct equiti postion cetus 40 mln dlrs attempt squibb major major holder cetus fild told reuter interview squibb approach indic acquir wouldnt interest kind arrang fild squibb reach comment late comment fild squibb cetus pharmaceut partner equiti posit cetus eastman kodak ltek wr grace ltwr joint ventur cetus own equiti posit compani fild cetus ventur kodak develp diagnost product grace develop agricultur product earlier squibb cetus announc joint statement agreement principl form joint ventur develop biotechnolog product field part deal squibb licens cetus anticanc agent includ interleukin2 develop squibb sell drug japan market north american western europ wouldnt deal understood cetus build fulli integr busi north america europ fild squibb good partner squibb major joint ventur japan sale capabl market fild cetus shun licens arrang pharmaceut compani want build busi larg corpor invest small biotech firm squibb invest cetus made biotechnolog fild attract cetus want partner didnt relationship larg number biotechnolog compani fild strategi partner drug area diagnost agricultur biggest develop anticanc drug fild partnership squibb broaden compani reach big money make area cardiovascular antiinfect antiinflammatori market squibb investm 75 mln dlrs cetus research year squibb put 75 mln dlrs research develop make happen equiti posit part packag simpli demonstr serious partnership fild